Publication | Open Access

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

Lymphoid NeoplasiaOncologyMantle Cell LymphomaVersus CyclophosphamideMedicinePathologyPharmacotherapyLymphatic DiseasePharmacologyRadiation OncologyCancer Research